New hope to stop lung Cancer's comeback after surgery

NCT ID NCT06862869

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is following 800 people in China who have had surgery for a specific type of early-stage lung cancer. The goal is to see how well the drug alectinib works at keeping the cancer from coming back when taken after surgery. Researchers will track how long patients stay cancer-free, their quality of life, and any side effects of the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliated Cancer Hospital and Institute of Guangzhou Medical University
RECRUITING

Guangzhou, Guangzhou, 510095, China
Affiliated Hospital of Guangdong Medical University
RECRUITING

Zhanjiang, Guangdong, 524001, China
Affiliated Hospital of Nantong University
RECRUITING

Nantong, 226001, China
Affiliated Hospital of Zunyi Medical University
RECRUITING

Zunyi, 563000, China
Anhui Provincial Hospital
RECRUITING

Hefei, 230001, China
Changzhou First People's Hospital
RECRUITING

Changzhou, 213003, China
Chest disease hospital of Tianjin City
RECRUITING

Tianjin, China
General Hospital of Ningxia Medical University
RECRUITING

Yinchuan, 750004, China
Harbin Medical University Cancer Hospital
RECRUITING

Harbin, 150081, China
Hebei Medical University Fourth Hospital
RECRUITING

Shijiazhuang, 50011, China
Henan Provincial Chest Hospital
RECRUITING

Zhengzhou, Henan, 450003, China
Huai He Hospital of Henan University
RECRUITING

Kaifeng, Henan, 475001, China
Huzhou Central Hospital
RECRUITING

Huzhou, 313000, China
Jiangmen Central Hospital
RECRUITING

Jiangmen, 529030, China
Jiangsu Cancer Hospital
RECRUITING

Nanjing, 210000, China
Jiangsu Province Hospital
RECRUITING

Nanjing, 210008, China
Lanzhou University Second Hospital
RECRUITING

Lanzhou, 730030, China
Liaoning Provincial Cancer Hospital
RECRUITING

Shengyang, 110042, China
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
RECRUITING

Nanjing, 210008, China
Ningbo No.2 Hospital
RECRUITING

Ningbo, 315000, China
Peking University First Hospital
RECRUITING

Beijing, 100034, China
Shandong Provincial Hospital
RECRUITING

Jinan, 250021, China
Shanghai Chest Hospital
RECRUITING

Shanghai, 200030, China
Shanghai Pulmonary Hospital
RECRUITING

Shanghai, 200433, China
Shanxi Provincial Cancer Hospital
RECRUITING

Taiyuan, 030013, China
Taizhou Hospital of Zhejiang Province
RECRUITING

Taizhou, 317000, China
The First Affiliated Hospital of Xinjiang Medical University
RECRUITING

Ürümqi, Xinjiang, 830054, China
The First Affiliated Hospital, Chongqing Medical University
RECRUITING

Chongqing, 400016, China
The Second Affiliated Hospital of Dalian Medical University
RECRUITING

Dalian, 116027, China
The Third Affiliated Hospital of Sun Yat-Sen University
RECRUITING

Guangzhou, 510630, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
RECRUITING

Wuhan, 430030, China
Wuxi People's Hospital
RECRUITING

Wuxi, 214023, China
Xi'an International Medical Center Hospital
RECRUITING

Xi'an, 710100, China
Xuanwu Hospital, Capital Medical University
ACTIVE_NOT_RECRUITING

Beijing, 100053, China
Zhejiang Cancer Hospital
RECRUITING

Hangzhou, 310022, China
Zhongshan Hospital Fudan University
RECRUITING

Shanghai, 200032, China

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG